We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer.
- Authors
Hurley, Judith; Doliny, Philomena; Reis, Isildinha; Silva, Orlando; Gomez-Fernandez, Carmen; Velez, Pedro; Pauletti, Giovanni; Powell, Jodeen E; Pegram, Mark D; Slamon, Dennis J
- Abstract
To evaluate the efficacy and safety of docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2 (HER2) -positive, locally advanced breast cancer (LABC).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Vol 24, Issue 12, p1831
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.02.8886